Subscribe To

Price Alert Latest News Economic Calendar News

TELA / TELA Bio, Inc. (TELA) CEO Antony Koblish on Q1 2022 Results - Earnings Call Transcript

TELA Bio, Inc. (NASDAQ:TELA ) Q1 2022 Results Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Louisa Smith - Investor Relations Antony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Zachary Weiner - Jefferies David Turkaly - JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Read More

Demo Live Account See Partner Details

Content Topics

TELA

Bio

Inc

Antony

Koblish

2022

Results

Earnings

tela

Transcript

Stock

Posted: May 14 2022, 16:59

Author Name: Seeking Alpha

TELA News

By Zacks Investment Research
August 9, 2023

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss

By Zacks Investment Research
June 19, 2023

Strength Seen in TELA Bio, Inc. (TELA): Can Its 11.4% Jump Turn into More Strength?

TELA Bio, Inc. (TELA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate re

By Seeking Alpha
May 14, 2023

TELA Bio, Inc. (TELA) Q1 2023 Earnings Call Transcript

TELA Bio, Inc. (NASDAQ:TELA ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Koblis

By Benzinga
April 19, 2023

Why TELA Bio Stock Is Dropping Today - TELA Bio (NASDAQ:TELA)

TELA Bio TELA shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share.

By Seeking Alpha
March 21, 2023

TELA Bio, Inc. (TELA) Q4 2022 Earnings Call Transcript

TELA Bio, Inc. (NASDAQ:TELA ) Q4 2022 Results Conference Call March 21, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Kobli

By Zacks Investment Research
March 21, 2023

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of 10.34% and 12.62%, respectively, for the quarter ended December 2022. Do the numbers

By GlobeNewsWire
February 28, 2023

TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results

MALVERN, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on p

By Seeking Alpha
November 12, 2022

TELA Bio, Inc. (TELA) Q3 2022 Earnings Call Transcript

TELA Bio, Inc. (NASDAQ:TELA ) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group Tony K

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.